Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]. Koller M, Musoro JZ, Tomaszewski K, Coens C, et al. Lung Cancer 2022 May 20. pii: S0169-5002(22)00436.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koller M, Musoro JZ, Tomaszewski K, Coens C, et al. Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]. Lung Cancer 2022 May 20. pii: S0169-5002(22)00436.
PMID: 35606221